Health care stocks were lower Monday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each shedding about 0.9%.
The iShares Biotechnology ETF (IBB) fell 1.3%.
In corporate news, Eli Lilly (LLY) has filed lawsuits against medical spas and online vendors for selling products claiming to contain tirzepatide, the main ingredient in its weight-loss drug Zepbound, Reuters reported. Eli Lilly shares declined 0.9%.
Cigna (CI) is continuing merger talks with Humana (HUM) after such discussions fell apart last year, Bloomberg reported Friday. Cigna shares fell 4.4% while Humana was down 1.9%.
LENZ Therapeutics (LENZ) said the US Food and Drug Administration has accepted its new drug application for its LNZ100 eye drops to treat presbyopia. Its shares rose over 3%.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。